ApoE genotype: No influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease

Jeroen Aerssens, Sean Lilienfeld, Peter Raeymaekers, Hugo Geerts, Frank Konings, Wim Parys
  • Neurobiology of Aging, May 2000, Elsevier
  • DOI: 10.1016/s0197-4580(00)82135-1

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/s0197-4580(00)82135-1

The following have contributed to this page: Hugo Geerts